The declining efficacy of naltrexone pharmacotherapy for alcohol use disorders over time: A multivariate meta-analysis

Alcoholism: Clinical and Experimental Research

Volumn 37, Issue 6, 2013, Pages 1064-1068

  Del Re, A C ^a   Maisel, Natalya ^a   Blodgett, Janet ^a   Finney, John ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcohol Treatment Research; Multivariate Meta Analysis; Naltrexone

Indexed keywords

NALTREXONE; PLACEBO;

ALCOHOL ABSTINENCE; ALCOHOL USE DISORDER; ALCOHOLISM; ARTICLE; DRUG EFFICACY; HUMAN; META ANALYSIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RELAPSE;

ALCOHOLISM; HUMANS; MULTIVARIATE ANALYSIS; NALTREXONE; NARCOTIC ANTAGONISTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84878392521     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/acer.12067     Document Type: Article

References (17)

1. Cooper HM, Hedges LV, Valentine JC (2009) The Handbook of Research Synthesis and Meta-Analysis. Russell Sage Foundation Publications, New York.
2. Del Re AC (2012) compute.es: Compute Effect Sizes [Statistical Software Program]. R Package Version 0.3. Madison, WI.
3. Del Re AC, Hoyt WT (2010) MAd: Meta-Analysis With Mean Differences [Statistical Software Program]. R Package Version 0.8. Madison, WI.
4. Del Re AC, Maisel NC, Blodgett JC, Wilbourne PL, Finney JW (in press) Placebo group improvement in trials of pharmacotherapies for alcohol use disorders: a multivariate meta-analysis examining change over time. J Clin Psychopharmacol.
5. Feinn R, Kranzler HR (2005) Does effect size in naltrexone trials for alcohol dependence differ for single-site vs. multi-center studies? Alcohol Clin Exp Res 29:983-988.
6. Finney JW (2008) Regression to the mean in substance use disorder treatment research. Addiction 103:42-52.
7. Gasparrini A (2011) mvmeta: Multivariate Meta-Analysis and Meta-Regression [Statistical Software Program]. R Package Version 0.2.4. London, UK.
8. Harris A, Kivlahan DR, Bowe T, Humphreys KN (2010) Pharmacotherapy of alcohol use disorders in the Veterans Health Administration. Psychiatr Serv 61:392-398.
9. Hedges LV (1981) Distribution theory for Glass's estimator of effect size and related estimators. J Educ Stat 6: 107-128.
10. Jackson D, Riley R, White IR (2011) Multivariate meta-analysis: potential and promise. Stat Med 30:2481-2498.
11. Kemp AS, Schooler NR, Kalali AH, Alphs L, Anand R, Awad G, Davidson M, Dubé S, Ereshefsky L, Gharabawi G, Leon AC, Lepine JP, Potkin SG, Vermeulen A (2010) What is causing the reduced drug-placebo difference in recent schizophrenia clinical trials and what can be done about it? Schizophr Bull 36:504-509.
12. Kirkham JJ, Riley RD, Williamson PR (2012) A multivariate meta-analysis approach for reducing the impact of outcome reporting bias in systematic reviews. Stat Med 31:2179-2195.
13. Maisel NC, Blodgett JC, Wilbourne PL, Humphreys K, Finney JW (in press) Meta-analysis of naltrexone and acamprosate for treating alcohol use disorders: when are these medications most helpful? Addiction doi: 10.1111/j.1360-0443.2012.04054.x [Epub ahead of print].
14. Rief W, Nestoriuc Y, Weiss S, Welzel E, Barsky AJ, Hofmann SG (2009) Meta-analysis of the placebo response in antidepressant trials. J Affect Disord 118:1-8.
15. Riley RD (2009) Multivariate meta-analysis: the effect of ignoring within-study correlation. J R Stat Soc Ser A Stat Soc 172:789-811.
16. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49:876-880.
17. Volpicelli JR, Clay KL, Watson NT, O'Brien CP (1995) Naltrexone in the treatment of alcoholism: predicting response to naltrexone. Clin Psychiatry 56:39-44.